ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.273,09
0,07%
S&P 500
6.086,37
0,61%
Dow Jones
44.156,73
0,30%
Euro vs US Dollar
1,04032
-0,05%
Bitcoin
102.224,46
-1,36%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. INmune Bio Inc (INMB)

  7. INmune Bio Inc (INMB) News

INMB

INmune Bio (INMB)

INmune Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INMB
DatumZeitQuelleÜberschriftSymbolFirma
15/01/202521h41Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:INMBINmune Bio Inc
09/12/202422h05Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:INMBINmune Bio Inc
09/12/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
09/12/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
09/12/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
09/12/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
09/12/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
09/12/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
14/11/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
13/11/202412h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
01/11/202421h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
31/10/202421h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INMBINmune Bio Inc
28/10/202421h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
25/10/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
24/10/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
11/10/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
26/09/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
17/09/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
17/09/202402h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
16/09/202416h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
16/09/202416h11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INMBINmune Bio Inc
03/09/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
09/08/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
09/08/202422h00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INMBINmune Bio Inc
08/08/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INMBINmune Bio Inc
02/08/202422h01Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:INMBINmune Bio Inc
02/08/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
01/08/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INMBINmune Bio Inc
30/07/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
19/07/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
 Showing the most relevant articles for your search:NASDAQ:INMB

Kürzlich von Ihnen besucht

USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
ADDYY
Adidas (QX)
CCOM
US100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
NASDAQ
MSFT
Microsoft
COIN
ADAUSD
Cardano
TG
DTE
Deutsche Telekom
COIN
XRPUSD
Ripple
TG
DBK
Deutsche Bank
TG
NOV
Novo Nordisk
TG
MBG
MercedesBenz
TG
BAS
BASF
NASDAQ
NVDA
NVIDIA
DBI
DAX
DAX
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten